MetaviaMTVA

13F holders, Q1 2024 (March 31)
13holders
$4.09avg. 13F price*

At the end of Q1 2024, 13 institutions reported holding Metavia Inc. (MTVA) in their 13F filings. The largest holders were Vanguard Group Inc. ($115K), Geode Capital Management, LLC ($85K) and State Street Corp. ($64K).

Company
Metavia Inc.
Filed as
NEUROBO PHARMACEUTICALS INC (Q1 2024)
CUSIP
64132R404
Latest filing quarter
Q3 2025

History

Number of 13F holders

05101520 Q1 2024: 13Q1 2024Q2 2024: 12Q2 2024Q3 2024: 13Q3 2024Q4 2024: 15Q4 2024Q1 2025: 14Q1 2025Q2 2025: 15Q2 2025Q3 2025: 16Q3 2025

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions6$285K
Exits1$154K

Ownership 13 holders

Vanguard Group Inc. 0.00% New 28,020 $115K
Geode Capital Management, LLC 0.00% Add +19.4% 20,703 $85K
State Street Corp. 0.00% New 15,633 $64K
Northern Trust Corp. 0.00% New 13,508 $55K
Susquehanna International Group, LLP 0.00% New 12,518 $51K
BlackRock Inc. 0.00% No change 5,274 $22K
Tower Research Capital LLC (TRC) 0.00% Reduce -23.4% 1,653 $7K
Wells Fargo & Company 0.00% No change 25 $102
Morgan Stanley 0.00% No change 25 $102
JPMorgan Chase & Co. 0.00% New 8 $33
BNP Paribas Financial Markets 0.00% New 4 $16
Comerica Bank 0.00% No change 2 $8
Bank of America Corp. 0.00% No change 1 $4

"% of holder's portfolio" is MTVA's weight in each manager's 13F, not the share of Metavia Inc. the manager owns.